Otros idiomas Lupin Limited NSE India S.E.

Acciones

LUPIN

INE326A01037

Mercado cerrado - NSE India S.E. Otros sitios de cotización 13:43:55 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
1.621 ^INR	+2,40 %		+3,87 %	+22,56 %

28/06	India planea incentivos para los fabricantes de medicamentos contra la diabetes y la obesidad en 2026, según un funcionario del gobierno	RE
28/06	Lupin pierde el recurso contra la multa antimonopolio de la UE	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

India plans incentives for diabetes, obesity drug makers in 2026, government official says	28/06
Indian Equities Fall on Friday, Dragged Mainly by Banking Stocks	28/06
Lupin Loses Appeal Against EU Anti-Trust Fine	28/06
Lupin : June 27, 2024 Lupin Receives Tentative Approval from U.S. FDA for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)	27/06
Lupin : June 22, 2024 Lupin Receives EIR from U.S. FDA for its Somerset Manufacturing Facility	22/06
Lupin : June 17, 2024 Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary	17/06
Lupin Appoints CEO for Subsidiary Lupin Manufacturing Solutions	17/06
Lupin : June 14, 2024 Lupin Announces Closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations	14/06
Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection	14/06
Lupin : June 12, 2024 Lupin and Fuji Sign License and Supply Agreement for Commercialization of Nextstellis™ in Vietnam and Philippines	12/06
Lupin : June 5, 2024 Lupin Completes Acquisition of two Brands from Sanofi in Europe and Canada	05/06
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada	05/06
Lupin : June 3, 2024 Lupin Receives Tentative Approval from U.S. FDA for Letermovir Tablets	03/06
Lupin : June 3, 2024 Lupin Launches Doxycycline for Injection USP in the United States	03/06
India's pharma export sales to grow faster this year, trade body says	30/05
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	27/05
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection	20/05
U.S. FDA Concludes a Pre Approval Inspection at Lupin's Somerset, New Jersey Manufacturing Facility	19/05
Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules	16/05
Lupin : May 15, 2024 Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office	15/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Lupin Limited NSE India S.E.

Acciones

LUPIN

INE326A01037

Otros idiomas

Filtros